Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Saba Capitalome & Opportunities Fund's earnings per share without non-recurring items for the
six
months ended in Apr. 2026 was $0.02.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Apr. 2026 was $0.78.
During the past 12 months, Saba Capitalome & Opportunities Fund's average earnings per share (NRI) Growth Rate was -34.90% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
During the past 8 years, Saba Capitalome & Opportunities Fund's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 72.50% per year. The lowest was 72.50% per year. And the median was 72.50% per year.
BRW's 3-Year EPS without NRI Growth Rate is not ranked *
in the Asset Management industry.
Industry Median: 13.1 * Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
Saba Capitalome & Opportunities Fund (NYSE:BRW) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Saba Capitalome & Opportunities Fund EPS without NRI Related Terms
Saba Capitalome & Opportunities Fund EPS without NRI Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saba Capitalome & Opportunities Fund EPS without NRI Chart
For the Asset Management subindustry, Saba Capitalome & Opportunities Fund's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saba Capitalome & Opportunities Fund PE Ratio without NRI vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Saba Capitalome & Opportunities Fund's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Saba Capitalome & Opportunities Fund's PE Ratio without NRI falls into.
Saba Capitalome & Opportunities Fund EPS without NRI Calculation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Apr. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.78
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saba Capitalome & Opportunities Fund (BRW) has a EPS without NRI of $0.78 as of Apr. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Saba Capitalome & Opportunities Fund and its competitors. According to the industry distribution chart, Saba Capitalome & Opportunities Fund ranks #999999 out of 829 companies in the Asset Management industry.
Is Saba Capitalome & Opportunities Fund's EPS without NRI too high?
Saba Capitalome & Opportunities Fund's current EPS without NRI is $0.78. The Asset Management industry median EPS without NRI is 13.10. Saba Capitalome & Opportunities Fund's value of $0.78 is 94% below this industry median. Based on the distribution chart, Saba Capitalome & Opportunities Fund ranks #999999 out of 829 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, Saba Capitalome & Opportunities Fund has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Saba Capitalome & Opportunities Fund's EPS without NRI compare to BGH and FUND?
According to the Asset Management industry distribution chart, Saba Capitalome & Opportunities Fund ranks #999999 out of 829 companies for EPS without NRI. This places Saba Capitalome & Opportunities Fund in the lower half of its industry. The industry median EPS without NRI is 13.10. Saba Capitalome & Opportunities Fund's value of $0.78 is 94% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for an Asset Management company?
The median EPS without NRI among Asset Management companies is 13.10, based on 829 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saba Capitalome & Opportunities Fund's current EPS without NRI of $0.78 is 94% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Saba Capitalome & Opportunities Fund and its competitors. For the Asset Management industry, the median EPS without NRI is 13.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saba Capitalome & Opportunities Fund's current EPS without NRI is $0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saba Capitalome & Opportunities Fund stock overvalued right now?
Based on GuruFocus' analysis, Saba Capitalome & Opportunities Fund (BRW) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.67, compared to a current price of $6.74 — trading 12.2% below its estimated fair value. The current EPS without NRI is $0.78 and 94% below the Asset Management industry median of 13.10. Saba Capitalome & Opportunities Fund's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Saba Capitalome & Opportunities Fund (BRW), the current EPS without NRI is $0.78 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Saba Capitalome & Opportunities Fund (BRW) Overvalued in 2026?
Based on GuruFocus' analysis, Saba Capitalome & Opportunities Fund stock appears to be undervalued.
The current stock price of $6.74 is trading 12.2% below its estimated GF Value™ of $7.67.
GuruFocus considers Saba Capitalome & Opportunities Fund to be Modestly Undervalued.
Key valuation signals for BRW:
EPS without NRI: $0.78
GF Value™: $7.67 vs. price of $6.74 (12.2% below fair value)
Industry Position: 94% below the Asset Management median (#999999 of 829)
No single metric tells the full story. See the BRW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Saba Capitalome & Opportunities Fund Business Description
Saba Capital Income & Opportunities Fund is a diversified, closed-end management investment company. It seeks to provide investors with a high level of current income, with a secondary goal of capital appreciation. It invests globally in debt and equity securities of public and private companies, which includes, investing in closed-end funds, public and private debt instruments, and other securities.
49GF Score
Get the complete analysis for BRW
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BRW has been successfully added to your 
